Percutaneous coronary intervention in Thammasat University Hospital: the first three-year experience

Dilok Piyayotai1, Pisit Hutayanon

  • 1Cardiology Unit, Department of Medicine, Faculty ofMedicine, Thammasat University, Pathumthani, Thailand. dilokp@tu.ac.th

Insights

Percutaneous coronary intervention (PCI) at Thammasat University Hospital demonstrated a high success rate of 95.57% with low in-hospital adverse events. This early experience highlights the safety and effectiveness of PCI in managing coronary artery disease.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Percutaneous coronary intervention (PCI) is a key revascularization strategy for coronary artery disease.
  • Establishing early outcomes is crucial for developing new interventional cardiology programs.

Purpose of the Study:

  • To evaluate the initial results and in-hospital outcomes of percutaneous coronary intervention (PCI) procedures.
  • To assess the safety and efficacy of a newly established cardiac catheterization laboratory.

Main Methods:

  • Prospective, single-center study including 617 patients undergoing 755 PCI procedures.
  • Data collection encompassed clinical characteristics, angiographic findings, and in-hospital adverse events.
  • Analysis focused on success rates and major adverse cardiac and cerebrovascular events (MACCE).

Main Results:

  • The overall angiographic success rate for PCI was 95.57%.
  • Major adverse events included death (0.93%), periprocedural myocardial infarction (3.17%), emergency coronary artery bypass graft (0.53%), and stroke (0.26%).
  • Indications for PCI included non-ST segment-elevation acute coronary syndrome (41.72%) and chronic stable angina (25.32%).

Conclusions:

  • The initial three years of PCI experience at Thammasat University Hospital show high procedural success.
  • In-hospital adverse outcomes were low, indicating a safe and effective early program.
  • These findings support the integration of PCI services in developing healthcare settings.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...